FIGURE SUMMARY
Title

Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline

Authors
Cornet, C., Di Donato, V., Terriente, J.
Source
Full text @ Front Pharmacol

Schematic representation of CRISPR/Cas9 techniques and applications in zebrafish. (Left) Graphical representation of CRISPR/Cas9-based methods available for genome engineering in zebrafish. Double strand break (DSB)-Dependent techniques: the Cas9 endonuclease/sgRNA complex induces DSB at the target genomic locus. The NHEJ (non-homologous end joining) DNA repair mechanism leads to the appearance of insertion/deletion (INDELs) which can result in a shift of the open reading frame of the targeted genomic locus, thereby causing gene inactivation (knockout: KO). The targeted insertion (knockin: KI) of donor DNA sequences coding for reporter genes (e.g., Gal 4 transcriptional trans-activator) is, in most reports, mediated by NHEJ. The Homology Directed Repair mechanism allows the precise integration of exogenous DNA at a chosen genomic locus. Single-stranded oligodeoxynucleotide (ssODN) or Double stranded vectors harboring homology arms (HA) can be used as donor DNA for the KI of point mutations and reporter genes. Double strand break (DSB)-independent techniques: modified versions of the Cas9 protein, not displaying endonuclease activity, are used. The fusion of a cytidine deaminase to a Cas9 nickase (nCas9) allows a DSB-independent irreversible conversion of one targeted base to another (Base Editing and introduction of Single Nucleotide Polymorphisms, SNPs). Dead Cas9 (dCas9), when fused to a repressor domain or activator domain, can interact to either activate or repress transcription. (Right) Table describing the applications of CRISPR/Cas9-based methods depicted in the left panel.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Front Pharmacol